Click here to get full coverage on IGC Pharma Achieves 65% Enrollment In Phase 2 CALMA Trial For Alzheimer's Agitation - Nasdaq

IGC Pharma Achieves 65% Enrollment In Phase 2 CALMA Trial For Alzheimer's Agitation  Nasdaq

IGC Pharma Achieves 65% Enrollment In Phase 2 CALMA Trial For Alzheimer's Agitation - Nasdaq

Click here to get full coverage on IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial - Yahoo Finance

IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial  Yahoo Finance

IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $IGC Given $4.8 Price Target - Quiver Quantitative

New Analyst Forecast: $IGC Given $4.8 Price Target  Quiver Quantitative

New Analyst Forecast: $IGC Given $4.8 Price Target - Quiver Quantitative

Click here to get full coverage on MOST Intergovernmental Council (IGC) - UNESCO

MOST Intergovernmental Council (IGC)  UNESCO

MOST Intergovernmental Council (IGC) - UNESCO

Click here to get full coverage on IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75." - Markets Financial Content

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75."  Markets Financial Content

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75." - Markets Financial Content

Click here to get full coverage on IGC Pharma announces publication of caregiver book on Alzheimer’s - MSN

IGC Pharma announces publication of caregiver book on Alzheimer’s  MSN

IGC Pharma announces publication of caregiver book on Alzheimer’s - MSN

Click here to get full coverage on IGC scores well in customer satisfaction - Post Register

IGC scores well in customer satisfaction  Post Register

IGC scores well in customer satisfaction - Post Register

Click here to get full coverage on India Capital Growth (LON:IGC) Trading 1.3% Higher - What's Next? - MarketBeat

India Capital Growth (LON:IGC) Trading 1.3% Higher - What's Next?  MarketBeat

India Capital Growth (LON:IGC) Trading 1.3% Higher - What's Next? - MarketBeat

Click here to get full coverage on IGC Pharma (IGC): Ascendiant Capital Raises Price Target to $4.7 - GuruFocus

IGC Pharma (IGC): Ascendiant Capital Raises Price Target to $4.7  GuruFocus

IGC Pharma (IGC): Ascendiant Capital Raises Price Target to $4.7 - GuruFocus

Click here to get full coverage on IGC Pharma reports 65% patient enrollment in Phase 2 CALMA trial - TipRanks

IGC Pharma reports 65% patient enrollment in Phase 2 CALMA trial  TipRanks

IGC Pharma reports 65% patient enrollment in Phase 2 CALMA trial - TipRanks

Click here to get full coverage on IGC expects all-time high in rapeseed area for the 2026/27 marketing year - Biofuels International

IGC expects all-time high in rapeseed area for the 2026/27 marketing year  Biofuels International

IGC expects all-time high in rapeseed area for the 2026/27 marketing year - Biofuels International

Click here to get full coverage on IGC: Bumper harvests boost global grain stocks - World-Grain.com

IGC: Bumper harvests boost global grain stocks  World-Grain.com

IGC: Bumper harvests boost global grain stocks - World-Grain.com

Click here to get full coverage on IGC Pharma : Announces Coverage Report by Ascendiant Capital Markets about the “Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75.” - marketscreener.com

IGC Pharma : Announces Coverage Report by Ascendiant Capital Markets about the “Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75.”  marketscreener.com

IGC Pharma : Announces Coverage Report by Ascendiant Capital Markets about the “Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75.” - marketscreener.com

Click here to get full coverage on IGC Pharma Announces Publication of Landmark Caregiver Book on Alzheimer's Disease - Yahoo Finance

IGC Pharma Announces Publication of Landmark Caregiver Book on Alzheimer's Disease  Yahoo Finance

IGC Pharma Announces Publication of Landmark Caregiver Book on Alzheimer's Disease - Yahoo Finance

Click here to get full coverage on IGC Achieves Significant Enrollment Progress in Phase 2 Alzheimer's Trial - GuruFocus

IGC Achieves Significant Enrollment Progress in Phase 2 Alzheimer's Trial  GuruFocus

IGC Achieves Significant Enrollment Progress in Phase 2 Alzheimer's Trial - GuruFocus

Click here to get full coverage on Ascendiant Capital Maintains IGC Pharma (IGC) Buy Recommendation - Nasdaq

Ascendiant Capital Maintains IGC Pharma (IGC) Buy Recommendation  Nasdaq

Ascendiant Capital Maintains IGC Pharma (IGC) Buy Recommendation - Nasdaq

Click here to get full coverage on IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75." - Corsicana Daily Sun

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75."  Corsicana Daily Sun

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75." - Corsicana Daily Sun

Click here to get full coverage on IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline - Yahoo Finance

IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline  Yahoo Finance

IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline - Yahoo Finance

Click here to get full coverage on IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial - Eagle-Tribune

IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial  Eagle-Tribune

IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial - Eagle-Tribune

Click here to get full coverage on IGC forecasts rise in global rapeseed planted area in 2026/27 driven by expansion in Asia - Oils & Fats International

IGC forecasts rise in global rapeseed planted area in 2026/27 driven by expansion in Asia  Oils & Fats International

IGC forecasts rise in global rapeseed planted area in 2026/27 driven by expansion in Asia - Oils & Fats International

Click here to get full coverage on IGC Pharma Leverages MINT-AD to Identify Socioeconomic Risk Factors Driving Alzheimer's and Aging Trends - Yahoo Finance

IGC Pharma Leverages MINT-AD to Identify Socioeconomic Risk Factors Driving Alzheimer's and Aging Trends  Yahoo Finance

IGC Pharma Leverages MINT-AD to Identify Socioeconomic Risk Factors Driving Alzheimer's and Aging Trends - Yahoo Finance

Click here to get full coverage on FSU’s IGC hosts Constitution Day event featuring Rich Lowry, editor of the National Review - FSView & Florida Flambeau

FSU’s IGC hosts Constitution Day event featuring Rich Lowry, editor of the National Review  FSView & Florida Flambeau

FSU’s IGC hosts Constitution Day event featuring Rich Lowry, editor of the National Review - FSView & Florida Flambeau

Click here to get full coverage on IGC Pharma Advances to Semi-Finals in the Alzheimer's Insights AI Prize with "AHA: Agentic Harmonization Assistant" - BioSpace

IGC Pharma Advances to Semi-Finals in the Alzheimer's Insights AI Prize with "AHA: Agentic Harmonization Assistant"  BioSpace

IGC Pharma Advances to Semi-Finals in the Alzheimer's Insights AI Prize with "AHA: Agentic Harmonization Assistant" - BioSpace

Click here to get full coverage on IGC Pharma Reports Accelerated Q2 Progress and Strengthened Financial Focus: CALMA Trial Passes 50% Enrollment Milestone, Strategic Divestiture Optimizes Capital - Yahoo Finance

IGC Pharma Reports Accelerated Q2 Progress and Strengthened Financial Focus: CALMA Trial Passes 50% Enrollment Milestone, Strategic Divestiture Optimizes Capital  Yahoo Finance

IGC Pharma Reports Accelerated Q2 Progress and Strengthened Financial Focus: CALMA Trial Passes 50% Enrollment Milestone, Strategic Divestiture Optimizes Capital - Yahoo Finance

Click here to get full coverage on IGC Pharma Inc (IGC) Q2 2026 Earnings Call Highlights: Strategic Advances and Financial Maneuvers - Yahoo Finance

IGC Pharma Inc (IGC) Q2 2026 Earnings Call Highlights: Strategic Advances and Financial Maneuvers  Yahoo Finance

IGC Pharma Inc (IGC) Q2 2026 Earnings Call Highlights: Strategic Advances and Financial Maneuvers - Yahoo Finance

Click here to get full coverage on IGC sees corn output spiking on increased US production - World-Grain.com

IGC sees corn output spiking on increased US production  World-Grain.com

IGC sees corn output spiking on increased US production - World-Grain.com

Click here to get full coverage on FSU's Institute for Governance and Civics receives $1.7 million U.S. Department of Education grant to launch Founding Voices project - Florida State University News

FSU's Institute for Governance and Civics receives $1.7 million U.S. Department of Education grant to launch Founding Voices project  Florida State University News

FSU's Institute for Governance and Civics receives $1.7 million U.S. Department of Education grant to launch Founding Voices project - Florida State University News

Click here to get full coverage on IGC: Global grain supply to reach new heights - World-Grain.com

IGC: Global grain supply to reach new heights  World-Grain.com

IGC: Global grain supply to reach new heights - World-Grain.com

Click here to get full coverage on IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates  Yahoo Finance

IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on Groups urge new site for IGC: ‘This property checks all the boxes’ - Valley Roadrunner

Groups urge new site for IGC: ‘This property checks all the boxes’  Valley Roadrunner

Groups urge new site for IGC: ‘This property checks all the boxes’ - Valley Roadrunner

Click here to get full coverage on Global rapeseed area set to rise as Asia drives expansion, says IGC - Biofuels International

Global rapeseed area set to rise as Asia drives expansion, says IGC  Biofuels International

Global rapeseed area set to rise as Asia drives expansion, says IGC - Biofuels International

Click here to get full coverage on IGC: Grains production outlook rises again - World-Grain.com

IGC: Grains production outlook rises again  World-Grain.com

IGC: Grains production outlook rises again - World-Grain.com

Click here to get full coverage on Earnings call transcript: IGC Pharma’s Q2 2025 results highlight Alzheimer’s trial progress - Investing.com

Earnings call transcript: IGC Pharma’s Q2 2025 results highlight Alzheimer’s trial progress  Investing.com

Earnings call transcript: IGC Pharma’s Q2 2025 results highlight Alzheimer’s trial progress - Investing.com

Click here to get full coverage on IGC Pharma Announces Preclinical Data Demonstrating TGR-63’s Dual Action on Alzheimer’s Pathology - Yahoo Finance

IGC Pharma Announces Preclinical Data Demonstrating TGR-63’s Dual Action on Alzheimer’s Pathology  Yahoo Finance

IGC Pharma Announces Preclinical Data Demonstrating TGR-63’s Dual Action on Alzheimer’s Pathology - Yahoo Finance

Click here to get full coverage on IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida's Department of Psychiatry and Behavioral Neurosciences - BioSpace

IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida's Department of Psychiatry and Behavioral Neurosciences  BioSpace

IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida's Department of Psychiatry and Behavioral Neurosciences - BioSpace

Click here to get full coverage on IGC Pharma to Host Mid-Year Fiscal 2026 Shareholder Update Call on November 17, 2025 - Yahoo Finance

IGC Pharma to Host Mid-Year Fiscal 2026 Shareholder Update Call on November 17, 2025  Yahoo Finance

IGC Pharma to Host Mid-Year Fiscal 2026 Shareholder Update Call on November 17, 2025 - Yahoo Finance

Click here to get full coverage on All You Need to Know About IGC Pharma, Inc. (IGC) Rating Upgrade to Strong Buy - Nasdaq

All You Need to Know About IGC Pharma, Inc. (IGC) Rating Upgrade to Strong Buy  Nasdaq

All You Need to Know About IGC Pharma, Inc. (IGC) Rating Upgrade to Strong Buy - Nasdaq

Click here to get full coverage on IGC: Global wheat crop developing nicely - World-Grain.com

IGC: Global wheat crop developing nicely  World-Grain.com

IGC: Global wheat crop developing nicely - World-Grain.com

Click here to get full coverage on IGC Pharma introduces AI platform to predict Alzheimer's risk - AuntMinnie

IGC Pharma introduces AI platform to predict Alzheimer's risk  AuntMinnie

IGC Pharma introduces AI platform to predict Alzheimer's risk - AuntMinnie

Click here to get full coverage on Earnings call transcript: IGC Pharma Q4 2025 focuses on Alzheimer’s trials - Investing.com

Earnings call transcript: IGC Pharma Q4 2025 focuses on Alzheimer’s trials  Investing.com

Earnings call transcript: IGC Pharma Q4 2025 focuses on Alzheimer’s trials - Investing.com

Click here to get full coverage on How 2025 became "a dream come true" for IGC Champion Pilot of the Year Jeroen Jennen - FAI | World Air Sports Federation

How 2025 became "a dream come true" for IGC Champion Pilot of the Year Jeroen Jennen  FAI | World Air Sports Federation

How 2025 became "a dream come true" for IGC Champion Pilot of the Year Jeroen Jennen - FAI | World Air Sports Federation

Click here to get full coverage on IGC: Global grains carryover to reverse course - World-Grain.com

IGC: Global grains carryover to reverse course  World-Grain.com

IGC: Global grains carryover to reverse course - World-Grain.com

Click here to get full coverage on IGC Pharma expands CALMA Phase 2 trial with Ichor Research site - MSN

IGC Pharma expands CALMA Phase 2 trial with Ichor Research site  MSN

IGC Pharma expands CALMA Phase 2 trial with Ichor Research site - MSN

Click here to get full coverage on IGC Pharma posts promising interim data for Alzheimer’s therapy - Clinical Trials Arena

IGC Pharma posts promising interim data for Alzheimer’s therapy  Clinical Trials Arena

IGC Pharma posts promising interim data for Alzheimer’s therapy - Clinical Trials Arena

Click here to get full coverage on 600M authorized shares: IGC Pharma boosts authorization, grants 5,000,000 shares and elects two directors - Stock Titan

600M authorized shares: IGC Pharma boosts authorization, grants 5,000,000 shares and elects two directors  Stock Titan

600M authorized shares: IGC Pharma boosts authorization, grants 5,000,000 shares and elects two directors - Stock Titan

Click here to get full coverage on IGC Pharma (NYSE American: IGC) sets shareholder update webcast for Nov. 17, 2025 - Stock Titan

IGC Pharma (NYSE American: IGC) sets shareholder update webcast for Nov. 17, 2025  Stock Titan

IGC Pharma (NYSE American: IGC) sets shareholder update webcast for Nov. 17, 2025 - Stock Titan

Click here to get full coverage on IGC Pharma Expands CALMA Phase 2 Trial to Island Health's Royal Jubilee Hospital in Canada - BioSpace

IGC Pharma Expands CALMA Phase 2 Trial to Island Health's Royal Jubilee Hospital in Canada  BioSpace

IGC Pharma Expands CALMA Phase 2 Trial to Island Health's Royal Jubilee Hospital in Canada - BioSpace

Click here to get full coverage on IGC Pharma (NYSE American: IGC) hits 50% CALMA enrollment, sells facility for $2.7M - Stock Titan

IGC Pharma (NYSE American: IGC) hits 50% CALMA enrollment, sells facility for $2.7M  Stock Titan

IGC Pharma (NYSE American: IGC) hits 50% CALMA enrollment, sells facility for $2.7M - Stock Titan

Click here to get full coverage on IGC Pharma, Inc. (IGC) Reports Q2 Loss, Misses Revenue Estimates - Nasdaq

IGC Pharma, Inc. (IGC) Reports Q2 Loss, Misses Revenue Estimates  Nasdaq

IGC Pharma, Inc. (IGC) Reports Q2 Loss, Misses Revenue Estimates - Nasdaq

Click here to get full coverage on IGC adds new clinical site in Canada for Alzheimer’s agitation therapy trial - Clinical Trials Arena

IGC adds new clinical site in Canada for Alzheimer’s agitation therapy trial  Clinical Trials Arena

IGC adds new clinical site in Canada for Alzheimer’s agitation therapy trial - Clinical Trials Arena

Click here to get full coverage on IGC Lowers Global Corn Production Forecast, Raises Wheat Crop - AgWeb

IGC Lowers Global Corn Production Forecast, Raises Wheat Crop  AgWeb

IGC Lowers Global Corn Production Forecast, Raises Wheat Crop - AgWeb

Click here to get full coverage on IGC Industries Sees Revision in Market Evaluation Amid Challenging Financials - Markets Mojo

IGC Industries Sees Revision in Market Evaluation Amid Challenging Financials  Markets Mojo

IGC Industries Sees Revision in Market Evaluation Amid Challenging Financials - Markets Mojo

Click here to get full coverage on IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders - Newswire.com

IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders  Newswire.com

IGC Pharma Announces Results of 2025 Annual Meeting of Stockholders - Newswire.com

Click here to get full coverage on IGC Pharma (NYSE American: IGC) adds docking and toxicology tools to in‑silico platform - Stock Titan

IGC Pharma (NYSE American: IGC) adds docking and toxicology tools to in‑silico platform  Stock Titan

IGC Pharma (NYSE American: IGC) adds docking and toxicology tools to in‑silico platform - Stock Titan

Click here to get full coverage on Oman's IGC approves transfer of Ghazeer pipeline to OQ Gas Networks - TradeArabia

Oman's IGC approves transfer of Ghazeer pipeline to OQ Gas Networks  TradeArabia

Oman's IGC approves transfer of Ghazeer pipeline to OQ Gas Networks - TradeArabia

Click here to get full coverage on New Strong Buy Stocks for Oct. 24: IGC, ASM and More - Yahoo Finance

New Strong Buy Stocks for Oct. 24: IGC, ASM and More  Yahoo Finance

New Strong Buy Stocks for Oct. 24: IGC, ASM and More - Yahoo Finance

Click here to get full coverage on IGC: Corn driving projected record grains output - World-Grain.com

IGC: Corn driving projected record grains output  World-Grain.com

IGC: Corn driving projected record grains output - World-Grain.com

Click here to get full coverage on IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease - Yahoo Finance

IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease  Yahoo Finance

IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease - Yahoo Finance

Click here to get full coverage on IGC Pharma Sells Vancouver Assets to Wellness Essentials - TipRanks

IGC Pharma Sells Vancouver Assets to Wellness Essentials  TipRanks

IGC Pharma Sells Vancouver Assets to Wellness Essentials - TipRanks

Click here to get full coverage on IGC Pharma (NYSE American: IGC) granted U.S. Patent 12,465,589 for IGC-AD1 in Alzheimer’s - Stock Titan

IGC Pharma (NYSE American: IGC) granted U.S. Patent 12,465,589 for IGC-AD1 in Alzheimer’s  Stock Titan

IGC Pharma (NYSE American: IGC) granted U.S. Patent 12,465,589 for IGC-AD1 in Alzheimer’s - Stock Titan

Click here to get full coverage on IGC Pharma Reports Progress Amid Financial Losses - TipRanks

IGC Pharma Reports Progress Amid Financial Losses  TipRanks

IGC Pharma Reports Progress Amid Financial Losses - TipRanks

Click here to get full coverage on IGC clean up nets 480 pounds of trash - SouthTexasNews.com

IGC clean up nets 480 pounds of trash  SouthTexasNews.com

IGC clean up nets 480 pounds of trash - SouthTexasNews.com

Click here to get full coverage on IGC Pharma (NYSE American: IGC) semi-finalist in $1M Alzheimer's AI Prize; AHA on Dec 5 - Stock Titan

IGC Pharma (NYSE American: IGC) semi-finalist in $1M Alzheimer's AI Prize; AHA on Dec 5  Stock Titan

IGC Pharma (NYSE American: IGC) semi-finalist in $1M Alzheimer's AI Prize; AHA on Dec 5 - Stock Titan

Click here to get full coverage on IGC: Bumper corn crop expected in 2025-26 - World-Grain.com

IGC: Bumper corn crop expected in 2025-26  World-Grain.com

IGC: Bumper corn crop expected in 2025-26 - World-Grain.com

Click here to get full coverage on IGC Pharma earnings matched, revenue fell short of estimates - Investing.com

IGC Pharma earnings matched, revenue fell short of estimates  Investing.com

IGC Pharma earnings matched, revenue fell short of estimates - Investing.com

Click here to get full coverage on IGC Pharma subsidiary agrees to asset sale valued at $2.7 million - Investing.com

IGC Pharma subsidiary agrees to asset sale valued at $2.7 million  Investing.com

IGC Pharma subsidiary agrees to asset sale valued at $2.7 million - Investing.com

Click here to get full coverage on 2025 Top 100 Independent Garden Centers List - gardencentermag.com

2025 Top 100 Independent Garden Centers List  gardencentermag.com

IGC

Price Chart

Key Statistics

Top 10 Holdings Distribution

Technicals

About IGC

Latest News

IGC Pharma Achieves 65% Enrollment In Phase 2 CALMA Trial For Alzheimer's Agitation - Nasdaq

IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial - Yahoo Finance

New Analyst Forecast: $IGC Given $4.8 Price Target - Quiver Quantitative

Advanced Charts

Fund Information